Legal Disclaimer
You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.
South Dakota Slated to Get New Johnson & Johnson COVID-19 Vaccine
There is about to be a third COVID-19 vaccine option available in South Dakota.
Dakota News Now is reporting that the state is expecting to receive 7,000 doses of the new Johnson & Johnson COVID-19 vaccine this week, which will bring South Dakota s total allotment to just over 25,000 doses per week.
The latest vaccine offers something the existing Pfizer and Moderna treatments don t - a one-shot application.
Johnson & Johnson received emergency authorization from the Food & Drug Administration over the weekend (February 27) and the South Dakota Department of Health is in the process of devising a plan for distribution across the state.
Cincinnati, Northern Kentucky played a large part in the trial of the Johnson & Johnson vaccine
A third COVID-19 vaccine option could soon be on the way â a panel unanimously approved the Emergency Authorization Use for the Johnson & Johnson vaccine Friday afternoon. FDA approval could be granted shortly.
and last updated 2021-02-26 23:19:49-05
COVINGTON, Ky. â A third COVID-19 vaccine option could soon be on the way â a panel unanimously recommended the emergency use authorization for the Johnson & Johnson vaccine Friday afternoon, and FDA approval could be granted shortly.
The worldâs largest trial for the Johnson & Johnson vaccine was headed up in Covington.
Legal Disclaimer
You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.
Bengaluru-based Strides Pharma has 127 cumulative abbreviated new drug applications (ANDA) filings with USFDA of which 96 have been approved and 31 are pending approval.